Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucagon-Like Peptide 1 | 7 | 2015 | 67 | 1.720 |
Why?
|
| Receptors, Calcitriol | 3 | 2022 | 134 | 1.670 |
Why?
|
| Glucose | 8 | 2022 | 1248 | 1.390 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 1362 | 1.380 |
Why?
|
| Vitamin D | 4 | 2022 | 261 | 1.360 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 84 | 1.240 |
Why?
|
| Bariatric Surgery | 3 | 2024 | 107 | 1.210 |
Why?
|
| Insulin | 6 | 2023 | 1454 | 1.110 |
Why?
|
| Hypothalamus | 4 | 2020 | 255 | 1.080 |
Why?
|
| Receptors, Glucagon | 2 | 2014 | 36 | 0.980 |
Why?
|
| Acanthosis Nigricans | 1 | 2022 | 15 | 0.860 |
Why?
|
| Body Height | 2 | 2013 | 231 | 0.850 |
Why?
|
| Obesity | 9 | 2024 | 2884 | 0.820 |
Why?
|
| Growth Disorders | 2 | 2013 | 218 | 0.810 |
Why?
|
| Brain | 4 | 2021 | 4113 | 0.790 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 115 | 0.790 |
Why?
|
| Calcitriol | 1 | 2020 | 127 | 0.710 |
Why?
|
| Methylphenidate | 1 | 2020 | 103 | 0.700 |
Why?
|
| Pediatric Obesity | 3 | 2022 | 364 | 0.700 |
Why?
|
| Hypothalamic Diseases | 1 | 2020 | 66 | 0.700 |
Why?
|
| Weight Loss | 2 | 2022 | 627 | 0.700 |
Why?
|
| Vitamins | 1 | 2020 | 157 | 0.690 |
Why?
|
| Leptin | 1 | 2020 | 295 | 0.670 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 353 | 0.660 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 225 | 0.650 |
Why?
|
| Diet, High-Fat | 3 | 2016 | 241 | 0.640 |
Why?
|
| Health Education | 1 | 2020 | 309 | 0.620 |
Why?
|
| Physician's Role | 1 | 2020 | 238 | 0.620 |
Why?
|
| Counseling | 1 | 2020 | 381 | 0.600 |
Why?
|
| Glucose Tolerance Test | 2 | 2016 | 213 | 0.580 |
Why?
|
| Obesity, Morbid | 3 | 2024 | 224 | 0.570 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 390 | 0.570 |
Why?
|
| Anorexia | 2 | 2014 | 143 | 0.560 |
Why?
|
| Eating | 3 | 2014 | 421 | 0.530 |
Why?
|
| Venoms | 2 | 2014 | 23 | 0.520 |
Why?
|
| Appetite Depressants | 1 | 2014 | 21 | 0.490 |
Why?
|
| Insulin Resistance | 3 | 2021 | 731 | 0.490 |
Why?
|
| Homeostasis | 6 | 2022 | 950 | 0.490 |
Why?
|
| Pediatrics | 2 | 2013 | 1141 | 0.480 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2013 | 20 | 0.470 |
Why?
|
| Hypoglycemic Agents | 3 | 2014 | 586 | 0.470 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 1678 | 0.460 |
Why?
|
| Cancer Survivors | 1 | 2020 | 650 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 830 | 0.430 |
Why?
|
| Fluorocarbons | 2 | 2023 | 63 | 0.430 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 1054 | 0.430 |
Why?
|
| Environmental Pollutants | 2 | 2023 | 83 | 0.420 |
Why?
|
| Gastric Bypass | 3 | 2024 | 81 | 0.410 |
Why?
|
| Rats, Long-Evans | 6 | 2020 | 101 | 0.410 |
Why?
|
| Internship and Residency | 1 | 2021 | 1375 | 0.360 |
Why?
|
| Overweight | 3 | 2022 | 484 | 0.340 |
Why?
|
| Neurons | 1 | 2020 | 2287 | 0.340 |
Why?
|
| Peptides | 2 | 2014 | 1479 | 0.340 |
Why?
|
| Energy Metabolism | 2 | 2011 | 992 | 0.330 |
Why?
|
| Quality of Life | 1 | 2022 | 4532 | 0.320 |
Why?
|
| Child | 12 | 2024 | 29154 | 0.320 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 421 | 0.300 |
Why?
|
| Learning | 2 | 2021 | 403 | 0.300 |
Why?
|
| Body Weight | 5 | 2016 | 1293 | 0.290 |
Why?
|
| Male | 19 | 2022 | 123000 | 0.290 |
Why?
|
| Animals | 15 | 2023 | 59536 | 0.270 |
Why?
|
| Adiposity | 2 | 2020 | 237 | 0.270 |
Why?
|
| Curriculum | 2 | 2021 | 860 | 0.260 |
Why?
|
| Rats | 7 | 2016 | 6086 | 0.260 |
Why?
|
| Gastrectomy | 3 | 2013 | 451 | 0.260 |
Why?
|
| Adolescent | 10 | 2024 | 31252 | 0.250 |
Why?
|
| Liraglutide | 2 | 2014 | 16 | 0.250 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2014 | 60 | 0.240 |
Why?
|
| Circulating MicroRNA | 1 | 2024 | 25 | 0.240 |
Why?
|
| Alkanesulfonic Acids | 1 | 2023 | 11 | 0.240 |
Why?
|
| Insulin, Regular, Human | 1 | 2023 | 12 | 0.230 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 4849 | 0.220 |
Why?
|
| Insulin-Secreting Cells | 2 | 2015 | 154 | 0.220 |
Why?
|
| Calcifediol | 1 | 2022 | 16 | 0.220 |
Why?
|
| Humans | 23 | 2024 | 261506 | 0.220 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 4143 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 6942 | 0.210 |
Why?
|
| Anti-Anxiety Agents | 1 | 2022 | 90 | 0.200 |
Why?
|
| Blood Glucose | 3 | 2023 | 1244 | 0.200 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2022 | 126 | 0.200 |
Why?
|
| Puberty | 1 | 2021 | 104 | 0.200 |
Why?
|
| Brain Chemistry | 1 | 2021 | 145 | 0.190 |
Why?
|
| Mice, Inbred ICR | 1 | 2021 | 239 | 0.190 |
Why?
|
| Fast Foods | 1 | 2020 | 31 | 0.190 |
Why?
|
| Meals | 1 | 2020 | 66 | 0.180 |
Why?
|
| Female | 10 | 2022 | 141928 | 0.180 |
Why?
|
| Mindfulness | 1 | 2020 | 58 | 0.170 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 414 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 5710 | 0.170 |
Why?
|
| Family | 1 | 2023 | 736 | 0.170 |
Why?
|
| Goals | 1 | 2020 | 185 | 0.170 |
Why?
|
| Mice | 6 | 2022 | 34495 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2023 | 986 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2020 | 417 | 0.160 |
Why?
|
| Educational Measurement | 1 | 2020 | 362 | 0.150 |
Why?
|
| Postprandial Period | 2 | 2013 | 85 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2022 | 808 | 0.140 |
Why?
|
| Young Adult | 4 | 2024 | 21445 | 0.140 |
Why?
|
| Health Behavior | 1 | 2020 | 603 | 0.130 |
Why?
|
| Electrophysiology | 1 | 2016 | 333 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2022 | 16273 | 0.130 |
Why?
|
| Central Nervous System | 2 | 2014 | 436 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 2291 | 0.120 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2013 | 26 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 7548 | 0.120 |
Why?
|
| Receptors, Ghrelin | 1 | 2013 | 35 | 0.120 |
Why?
|
| Glucose Clamp Technique | 1 | 2013 | 89 | 0.120 |
Why?
|
| Gastric Emptying | 1 | 2013 | 94 | 0.120 |
Why?
|
| Peripheral Nerves | 1 | 2014 | 159 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 116 | 0.120 |
Why?
|
| Ghrelin | 1 | 2013 | 79 | 0.110 |
Why?
|
| Glucokinase | 1 | 2012 | 21 | 0.110 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 85 | 0.110 |
Why?
|
| Adult | 5 | 2024 | 77950 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2021 | 1270 | 0.110 |
Why?
|
| Caloric Restriction | 1 | 2013 | 88 | 0.110 |
Why?
|
| Incretins | 1 | 2012 | 25 | 0.110 |
Why?
|
| Gene Expression | 1 | 2021 | 3570 | 0.110 |
Why?
|
| Hormones | 1 | 2013 | 266 | 0.110 |
Why?
|
| Cell Line | 1 | 2020 | 5114 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1171 | 0.110 |
Why?
|
| Rats, Wistar | 1 | 2013 | 562 | 0.100 |
Why?
|
| Organ Size | 1 | 2013 | 690 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2014 | 333 | 0.100 |
Why?
|
| Fasting | 1 | 2012 | 349 | 0.100 |
Why?
|
| Triglycerides | 1 | 2013 | 603 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2023 | 37905 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2024 | 2947 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 5687 | 0.090 |
Why?
|
| Gastric Mucosa | 1 | 2013 | 613 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 3639 | 0.090 |
Why?
|
| Lipids | 1 | 2013 | 644 | 0.090 |
Why?
|
| Health Care Costs | 1 | 2013 | 674 | 0.080 |
Why?
|
| Pregnancy | 1 | 2021 | 7573 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 1085 | 0.080 |
Why?
|
| Diet | 1 | 2013 | 1440 | 0.070 |
Why?
|
| Biopsy | 1 | 2013 | 3443 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 14889 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2021 | 2203 | 0.060 |
Why?
|
| Liver | 2 | 2024 | 2961 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2024 | 239 | 0.060 |
Why?
|
| Hyperphagia | 1 | 2022 | 45 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 21713 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2020 | 11965 | 0.050 |
Why?
|
| Algorithms | 1 | 2013 | 3890 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 82 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 14551 | 0.050 |
Why?
|
| Bone Density | 1 | 2024 | 476 | 0.050 |
Why?
|
| Fibrosis | 1 | 2024 | 793 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 229 | 0.050 |
Why?
|
| Cholesterol | 1 | 2023 | 658 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2023 | 9244 | 0.040 |
Why?
|
| Stomach | 2 | 2013 | 387 | 0.040 |
Why?
|
| Apoptosis | 1 | 2013 | 7591 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 235 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 562 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2021 | 576 | 0.040 |
Why?
|
| Infant | 1 | 2013 | 13310 | 0.040 |
Why?
|
| Parents | 1 | 2022 | 998 | 0.030 |
Why?
|
| Infusions, Intraventricular | 1 | 2013 | 29 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 2522 | 0.030 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2012 | 34 | 0.030 |
Why?
|
| Ribonucleotides | 1 | 2012 | 52 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 5047 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 1020 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 339 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1489 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2012 | 874 | 0.020 |
Why?
|
| United States | 1 | 2022 | 15433 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 17523 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 7222 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 70117 | 0.010 |
Why?
|
| Middle Aged | 1 | 2022 | 86204 | 0.010 |
Why?
|